Physician profile
Mark M Dolan
NPI 1821251125
$3,938.17
in general payments reported to CMS, 2019-2025
8 companies · $592 in 2025
The $592 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $344 · 2020: $956 · 2021: $100 · 2022: $611 · 2023: $175 · 2024: $1,161 · 2025: $592.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $983 · Travel and Lodging: $945.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $982.97 |
| Travel and Lodging | $944.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,543.13 | 2019-2025 | Mako, Triathlon |
| Encore Medical, LP | $874.90 | 2020-2024 | Djo Surgical |
| Sanara Medtech INC. | $202.40 | 2025 | Biasurge |
| Medacta USA, INC. | $105.43 | 2025 | Gmk Sphere |
| Orthalign INC | $100.00 | 2021 | |
| Zimmer Biomet Holdings, INC. | $75.31 | 2020-2025 | Mymobility Platform |
| Kci USA, INC. | $22.40 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $14.60 | 2024 | Iovera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Dolan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.